GlassScriptPhysician profile
Daniel Laurence Kapp
NPI 1235132416
$252,124.65
in general payments reported to CMS, 2019-2025
39 companies · $79K in 2025
The $79K reported for 2025 was more than what 99% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $4,760 · 2021: $18K · 2022: $43K · 2023: $28K · 2024: $62K · 2025: $79K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $111K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $37K · Travel and Lodging: $12K · Food and Beverage: $7,580 · Honoraria: $2,750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $111,062.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $36,825.50 |
| Travel and Lodging | $11,740.53 |
| Food and Beverage | $7,579.64 |
| Honoraria | $2,750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $221,177.83 | 2019-2025 | Affinity, Puraply Wound Matrix, Nushield |
| Tela Bio, INC. | $16,593.71 | 2021-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Allergan, INC. | $5,027.86 | 2019-2021 | |
| Davol INC. | $2,961.90 | 2023 | |
| Sientra, INC. | $1,132.74 | 2019-2022 | |
| Integra Lifesciences Corporation | $655.45 | 2019-2023 | Integra, Durasorb Monofilament Mesh, Primatrix |
| Royal Biologics, INC. | $609.99 | 2025 | |
| Mentor Worldwide LLC | $555.83 | 2024-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Smith+Nephew, INC. | $513.97 | 2019-2025 | Collagenase Santyl, Pico, Renasys Touch |
| Medline Industries LP | $512.68 | 2019-2022 | |
| Kerecis Limited | $507.30 | 2019-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Surgiclose |
| Hydrofera LLC | $170.91 | 2021-2022 | |
| Abbvie INC. | $154.74 | 2021-2024 | |
| Axogen | $153.97 | 2023 | Avance Nerve Graft |
| Acell, INC. | $143.68 | 2019-2020 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avita Medical Americas, LLC | $133.57 | 2024 | |
| Convatec INC. | $122.22 | 2021 | |
| Acera Surgical, INC. | $104.86 | 2021-2025 | Restrata Wound Matrix |
| Ets Wound Care LLC | $104.70 | 2023 | |
| Ethicon US, LLC | $94.18 | 2025 | Vistaseal, Dermabond Prineo |
| Reprise Biomedical, INC. | $86.97 | 2025 | Miro3d, Miro 3d |
| Musculoskeletal Transplant Foundation INC. | $84.89 | 2021-2025 | |
| Aroa Biosurgery Incorporated | $64.28 | 2023-2025 | |
| Kci USA, INC. | $57.03 | 2019-2023 | Prevena, V.A.C. Veraflo, V.A.C. Veraflo Cleanse Choice |
| Mimedx Group, INC. | $50.38 | 2024-2025 | |
| Osiris Therapeutics INC. | $49.13 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $38.30 | 2023 | Seglentis |
| Covidien LP | $34.59 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $33.24 | 2020-2021 | |
| Merz North America, INC. | $32.86 | 2021 | |
| Innovation Technologies INC | $25.70 | 2020 | |
| Acelrx Pharmaceuticals, INC. | $22.53 | 2021 | |
| Tactile Systems Technology INC | $22.48 | 2020 | |
| Urgo Medical North America, LLC | $20.62 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| Bsn Medical INC | $18.81 | 2019 | |
| Galderma Laboratories, L.P. | $18.44 | 2023 | |
| Fidia Pharma USA INC. | $14.55 | 2024 | |
| Polynovo North America LLC | $12.75 | 2022 | |
| Next Science LLC | $5.01 | 2023 | Blastx, Surgx, Xperience |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Kapp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.